-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HJzW+PV7RkLoJmrRdvms1pbf2XBoundVJoNxJHkhWDl2JGM/XIDvzX8QIPDGyy8m cFn0DnX4unLO7CyNHQImSQ== 0001104659-09-016494.txt : 20090311 0001104659-09-016494.hdr.sgml : 20090311 20090311170739 ACCESSION NUMBER: 0001104659-09-016494 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20090309 FILED AS OF DATE: 20090311 DATE AS OF CHANGE: 20090311 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McCleary Joel CENTRAL INDEX KEY: 0001409933 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32587 FILM NUMBER: 09673175 BUSINESS ADDRESS: BUSINESS PHONE: 410-269-2600 MAIL ADDRESS: STREET 1: C/O PHARMATHENE, INC STREET 2: ONE PARK PLACE, SUITE 450 CITY: ANNAPOLIS STATE: MD ZIP: 21401 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PHARMATHENE, INC CENTRAL INDEX KEY: 0001326190 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 202726770 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE PARK PLACE, SUITE 450 CITY: ANNAPOLIS STATE: MD ZIP: 21401 BUSINESS PHONE: 410 269 2600 MAIL ADDRESS: STREET 1: ONE PARK PLACE, SUITE 450 CITY: ANNAPOLIS STATE: MD ZIP: 21401 FORMER COMPANY: FORMER CONFORMED NAME: HEALTHCARE ACQUISITION CORP DATE OF NAME CHANGE: 20050505 4 1 a4.xml 4 X0303 4 2009-03-09 0 0001326190 PHARMATHENE, INC PIP 0001409933 McCleary Joel C/O PHARMATHENE, INC. ONE PARK PLACE, SUITE 450 ANNAPOLIS MD 21401 1 0 0 0 Stock option (right to buy) 2.59 2009-03-09 4 A 0 10000 A 2009-03-09 2018-06-13 Common Stock 10000 10000 D On March 9, 2009, the date such stock options were granted, the closing price of the Issuer's common stock was $2.53 per share. Exhibit List: Exhibit 24 - Confirming Statement /s/ Roland S. Chase, attorney in fact 2009-03-11 EX-24 2 ex-24.htm EX-24

Exhibit 24

 

CONFIRMING STATEMENT

 

This Statement confirms that the undersigned has authorized and designated Jordan P. Karp, Christopher C. Camut, Jeffrey A. Baumel and Roland S. Chase (the “Authorized Signatories”), or any one or more of them, to execute and file on the undersigned’s behalf all Forms 3, 4, and 5 (including any amendments thereto) that the undersigned may be required to file with the U.S. Securities and Exchange Commission as a result of the undersigned’s ownership of or transactions in securities of PharmAthene, Inc.  The authority of the Authorized Signatories  under this Statement shall continue until the undersigned is no longer required to file Forms 3, 4, and 5 with regard to his/her ownership of, or transactions in, securities of  PharmAthene, Inc., unless earlier revoked in writing.  The undersigned acknowledges that Authorized Signatories are not assuming any of the undersigned’s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.

 

 

Dated:

March 11, 2009

 

 

 

Signed:

/s/ Joel McCleary

 

 

 

Print Name:

/s/ Joel McCleary

 

 

 -----END PRIVACY-ENHANCED MESSAGE-----